Ms. Jenn Hepburn reports
EMERALD HEALTH THERAPEUTICS TO HOST 2019 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, MAY 14, 2020 AT 10:30 AM ET
Further to its news release on April 29, Emerald Health Therapeutics Inc. will release audited financial results for the fourth quarter and year ended Dec. 31, 2019, after the market close on Wednesday, May 13, 2020. The company will host a conference call on Thursday, May 14, 2020, at 10:30 a.m. Eastern Time.
An archived version of the presentation will be available for 90 days on the investors section of Emerald's website.
Emerald also announces that it has issued an aggregate of 1.5 million stock options to directors at an exercise price of 16.5 cents per common share for a period of five years. All stock options will vest immediately.
About Emerald Health Therapeutics Inc.
Emerald Health is committed to cutting-edge cannabis science to create new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products. With an emphasis on innovation and production excellence, Emerald's three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.